Symposium:
158. New and Near Available Anti-Infective Therapy
Saturday, October 5, 2013: 8:30 AM-10:00 AM
Room: The Moscone Center: 103 (Gateway Ballroom)
Co-organized with the American Society for Microbiology (ASM)/Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe newly available antibacterial, antiparasitic, and antifungal agents
  • discuss new agents expected to be available in the near future

Target Audience: scientists, researchers, pharmacists, nurses, microbiologists, members-in-training, investigators, infectious diseases physicians, infectious diseases pediatricians, fellows, clinicians, academicians

Tracks: Investigative ID, Global ID, Adult ID

Moderators:  David Andes, MD, University of Wisconsin and Paul G. Ambrose, PharmD, FIDSA, Institute of Clinical Pharmacodynamics

Presentations:

8:30 AM
Focus on New Antibacterials
Michael Dudley, PharmD

9:00 AM
Focus on Antiparasitics
Andrea Boggild, MD

9:30 AM
Focus on Antifungals
Thomas Patterson, MD, FIDSA

CME Credits: No CME credit offered for this session.

ACPE Credits: No CPE credit offered for this session.

ACPE Number: 0221-9999-13-109-L01-P - DENIED

Disclosures:

D. Andes, None

P. G. Ambrose, None

M. Dudley, Rempex Pharmaceuticals: Employee, Salary

A. Boggild, None

T. Patterson, Astellas: Consultant, Grant Investigator and Scientific Advisor, Consulting fee
Merck: Consultant, Grant Investigator and Scientific Advisor, Research grant and Speaker honorarium
Toyoma: Consultant and Scientific Advisor, Consulting fee
Viamet: Scientific Advisor, Research support

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.